December 23, 2014
Why is a payday loan right for you Payday loan 50 up to
Payday loans uk

HCV Care Cascade

Posted on November 6, 2014 by in Hep Talk, LifeGuide

LifeGuide [Hep Talk] Breaking the Bottlenecks A new focus on cascade of care seeks to expand screening & treatment by Larry Buhl Originally coined to describe the continuum of care—and the gaps in care—for people with HIV, the term cascade of care is now used for hepatitis C and other diseases. The cascade and number [...]

HCV Behind Bars: Part I

Posted on September 9, 2014 by in Hep Talk, LifeGuide

LifeGuide [Hep Talk] Treatment Behind Bars Part I: Who pays for direct-acting antiretrovirals in prisons? by Larry Buhl The new class of direct-acting antiretrovirals (DAAs) that have revolutionized treatment of hep C have greatly boosted the chances of recovery. The American Association for the Study of Liver Diseases and the Infectious Diseases Society of America [...]

HCV & Underreporting

Posted on May 13, 2014 by in Hep Talk, LifeGuide

By the Numbers While HCV prevalence is down, the rate of morbidity may be going up by Larry Buhl New data on the prevalence of hepatitis C virus (HCV) in the U.S. shows that, with a “silent epidemic,” it’s hard to get accurate numbers. A disease that often has no symptoms, and that hits populations [...]

Coffee & HCV

Posted on March 6, 2014 by in Hep Talk, LifeGuide

Coffee Talk Two studies shed light on HCV prevention & treatment by Larry Buhl A study on the long-term infectiousness of the hepatitis C virus (HCV) has implications for healthcare workers, IV drug users, and tattoo artists, while another study shows the benefits of coffee and tea on liver inflammation in chronic hepatitis C patients. [...]

HCV Serosorting

Posted on January 24, 2014 by in Hep Talk, LifeGuide

Testing, Testing Serosorting is common for IV drug users who know their HCV status by Larry Buhl A new study shows IV drug users who know they carry the hepatitis C virus are likely to consider their serostatus when deciding whether and with whom to share injection equipment. The results, published in the December 15, [...]

Direct-Acting Antivirals & HCV

Posted on December 31, 2013 by in Hep Talk, LifeGuide

Hep Talk by Larry Buhl Two Agents New direct-acting antivirals cross a major hurdle                       The Antiviral Drugs Advisory Committee of the U.S. Food and Drug Administration (FDA) in October gave unanimous recommendations for approval of two next-generation direct-acting antivirals (DAAs) for hepatitis C, Janssen’s [...]

Hep C & Adult Films

Posted on October 30, 2013 by in Hep Talk, LifeGuide

Hep Talk by Larry Buhl Hep X Does the porn industry have a hepatitis problem? Actors who work for legitimate adult entertainment producers, who are mostly based in Los Angeles, now have to submit to monthly tests for hepatitis B and C as well as for Trichomoniasis vaginalis, a sexually transmitted infection of the urogenital [...]

HCV Data Sharing

Posted on September 20, 2013 by in Hep Talk, LifeGuide

Hep Talk by Larry Buhl Three Steps New hep C data sharing may lead to more testing Last year the U.S. Centers for Disease Control and Prevention (CDC) made a big stir in the medical community when it issued its recommendation that everyone in the Baby Boomer cohort be tested for hepatitis C, whether or [...]

Hep C & the War on Drugs

Posted on July 12, 2013 by in Hep Talk, LifeGuide

Hep Talk by Larry Buhl The War on Common Sense A new report advocates decriminalizing drug use to reduce Hep C The so-called “war on drugs” is creating an epidemic of hepatitis C. That’s the finding of a new report by the Global Commission on Drug Policy, which finds that drug war policies have caused [...]

Man to Man

Posted on May 29, 2013 by in Hep Talk, LifeGuide

Hep Talk by Larry Buhl For MSMs: treatment hope for HCV—and a warning There’s more evidence of the effectiveness of new antiretroviral drugs in treating the hepatitis C virus (HCV). This time it’s a study, presented at the 20th Conference on Retroviruses and Opportunistic Infections (CROI 2013) in March in Atlanta, that showed adding telaprevir [...]